Early Administration of Intracoronary Verapamil Improves Myocardial Perfusion During Percutaneous Coronary Interventions for Acute Myocardial Infarction
Authors:
- Cha-Ping WangCWCha-Ping Wang
- Hon-Kan YipHYHon-Kan Yip
- Cheng-Hsu YangCYCheng-Hsu Yang
- G. Bih-Fang GuoGGG. Bih-Fang Guo
- Chiung-Jen WuCWChiung-Jen Wu
- Shyh-Ming ChenShyh-Ming Chen
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Refractory No-Reflow Successfully Treated with Local Infusion of High-Dose Adenosine and VerapamilAngiology, 2001
- Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCAHeart and Vessels, 1996
- Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1995
- Features and outcome of no-reflow after percutaneous coronary interventionThe American Journal of Cardiology, 1995
- Intracoronary diltiazem for microvascular spasm after interventional therapyThe American Journal of Cardiology, 1995
- Early and late angiographic findings of the “no-reflow” phenomenon following direct angioplasty as primary treatment for acute myocardial infarctionAmerican Heart Journal, 1992
- Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusionJACC, 1986
- Demonstration of the “no-reflow” phenomenon by digital coronary arteriographyThe American Journal of Cardiology, 1986
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974